Progressive, neurodegenerative disease characterized by memory loss.
1These same types of factors may also be associated with Alzheimer disease.
2The mechanism of neurodegeneration caused by beta-amyloid in Alzheimer disease is controversial.
3The pattern of pathological tau bands was like that of Alzheimer disease.
4Main outcomes and measures: Incident dementia and Alzheimer disease using standard diagnostic criteria.
5Results: Four patients with Alzheimer disease presented REM sleep with-out atonia.
6Background: Cognitive decline and Alzheimer disease are more prevalent in our aging population.
7Thus, inactivation of BACE1 could be important in the treatment of Alzheimer disease.
8This study evaluated whether gonadotropins may be associated with Alzheimer disease.
9The protease BACE1 is a major drug target in Alzheimer disease.
10A similar pathogenesis can be postulated for DA of Alzheimer disease.
11No changes were observed in the temporal cortex of postmortem Alzheimer disease brains.
12Background: Calculation deficits are a common early manifestation of Alzheimer disease (AD).
13The cohort was enriched for Alzheimer disease risk based on family history of dementia.
14Methods: A pilot phase 2 clinical trial in patients with moderately severe Alzheimer disease.
15The key role of APP in the pathogenesis of Alzheimer disease is well established.
16Development of disease-modifying therapeutics is urgently needed for treating Alzheimer disease (AD).
Translations for alzheimer disease